Lota S. Zoth - May 13, 2021 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role
Director
Signature
/s/ Lota Zoth
Stock symbol
INO
Transactions as of
May 13, 2021
Transactions value $
-$13,538
Form type
4
Date filed
5/17/2021, 04:29 PM
Previous filing
May 7, 2021
Next filing
May 24, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INO Common Stock Options Exercise +8.7K +57.12% 23.9K May 14, 2021 Direct F1
transaction INO Common Stock Sale -$13.5K -2.05K -8.55% $6.62* 21.9K May 17, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INO Common Stock Options Award $0 +27K $0.00 27K May 13, 2021 Common Stock 27K $6.23 Direct F3, F4
transaction INO Restricted Stock Unit Award $0 +18K $0.00 18K May 13, 2021 Common Stock 18K Direct F3, F5
transaction INO Restricted Stock Unit Options Exercise $0 -8.7K -100% $0.00* 0 May 14, 2021 Common Stock 8.7K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 14, 2021.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F3 This grant was made pursuant to the issuer's non-employee director compensation policy.
F4 Options to vest 100% on May 13, 2022.
F5 Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 13, 2022.